Iñaki Inza

Iñaki Inza

Auto-generated profile, based on publicly available information

Iñaki Inza

University of the Basque Country

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2007 in Bioinformatics
Verified
Journal Article
Open access
PDF file
YSYvan Saeys
Yvan Saeys
IIIñaki Inza
Iñaki Inza
PLPedro Larrañaga
Pedro Larrañaga
Feature selection techniques have become an apparent need in many bioinformatics applications. In addition to the large pool of techniques that have already been developed in the machine learning and data mining fields, specific applications in bioinformatics have led to a wealth of newly proposed techniques. In this article, we make the interested reader aware of the possibilities of feature selection, providing a basic taxonomy of feature selection techniques, and discussing their use, variety and potential in a number of both common as well as upcoming bioinformatics applications. Contact:yvan.saeys@psb.ugent.be Supplementary information:http://bioinformatics.psb.ugent.be/supplementary_data/yvsae/fsreview

1 March 2006 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
PLPedro Larrañaga
Pedro Larrañaga
BCBorja Calvo
Borja Calvo
RSRoberto Santana
Roberto Santana
CBConcha Bielza
Concha Bielza
JGJosu Galdiano
Josu Galdiano
VRVictor Robles
Victor Robles
This article reviews machine learning methods for bioinformatics. It presents modelling methods, such as supervised classification, clustering and probabilistic graphical models for knowledge discovery, as well as deterministic and stochastic heuristics for optimization. Applications in genomics, proteomics, systems biology, evolution and text mining are also shown.

1 April 1999 in Artificial Intelligence Review
Verified
Journal Article
Closed access
PDF file
PLP. Larrañaga
P. Larrañaga
CKC.M.H. Kuijpers
C.M.H. Kuijpers
RMR.H. Murga
R.H. Murga
III. Inza
I. Inza
SDS. Dizdarevic
S. Dizdarevic

1 June 2004 in Artificial Intelligence in Medicine
Verified
Journal Article
Closed access
IIIñaki Inza
Iñaki Inza
PLPedro Larrañaga
Pedro Larrañaga
RBRosa Blanco
Rosa Blanco
ACAntonio J. Cerrolaza
Antonio J. Cerrolaza

20 July 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DODavid Otaegui
David Otaegui
SBSergio Baranzini
Sergio Baranzini
RARuben Armañanzas
Ruben Armañanzas
BCBorja Calvo
Borja Calvo
MMMaider Muñoz-Culla
Maider Muñoz-Culla
AMAdolfo López de Munain
Adolfo López de Munain
Differences in gene expression patterns have been documented not only in Multiple Sclerosis patients versus healthy controls but also in the relapse of the disease. Recently a new gene expression modulator has been identified: the microRNA or miRNA. The aim of this work is to analyze the possible role of miRNAs in multiple sclerosis, focusing on the relapse stage. We have analyzed the expression patterns of 364 miRNAs in PBMC obtained from multiple sclerosis patients in relapse status, in remission status and healthy controls. The expression patterns of the miRNAs with significantly different expression were validated in an independent set of samples. In order to determine the effect of the miRNAs, the expression of some predicted target genes of these were studied by qPCR. Gene interaction networks were constructed in order to obtain a co-expression and multivariate view of the experimental data. The data analysis and later validation reveal that two miRNAs (hsa-miR-18b and hsa-miR-599) may be relevant at the time of relapse and that another miRNA (hsa-miR-96) may be involved in remission. The genes targeted by hsa-miR-96 are involved in immunological pathways as Interleukin signaling and in other pathways as wnt signaling. This work highlights the importance of miRNA expression in the molecular mechanisms implicated in the disease. Moreover, the proposed involvement of these small molecules in multiple sclerosis opens up a new therapeutic approach to explore and highlight some candidate biomarker targets in MS.

1 October 2000 in Artificial Intelligence
Verified
Journal Article
Closed access
III. Inza
I. Inza
PLP. Larrañaga
P. Larrañaga
RER. Etxeberria
R. Etxeberria
BSBasilio Sierra
Basilio Sierra